Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Christopher M. Adams, Michael H. Serrano‐Wu et al.|Journal of Medicinal Chemistry|2020Cited by 61
High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular TissueJohn Reilly, Michael H. Serrano‐Wu, Sarah Williams et al.|Journal of Pharmaceutical Sciences|2015Cited by 21
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Michael H. Serrano‐Wu, Ricardo E. Chatelain et al.|Journal of Medicinal Chemistry|2017Cited by 18
Chemoselective Amination of 5-Bromo-2-chloro-3-fluoropyridineBryan W. Stroup, Michael H. Serrano‐Wu, Paul V. Szklennik et al.|Organic Letters|2007Cited by 18
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKatsumasa Nakajima, Bing Wang, Myriam April et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 5